Profilo
Attualmente, Brendan Smith ricopre la posizione di Senior VP, Chief Financial & Accounting Officer presso CRISPR Therapeutics AG. In passato Mr. Smith è stato Chief Financial Officer & Head-Corporate Strategy presso Translate Bio, Inc. e Partner & Associate Director presso The Boston Consulting Group, Inc. Si è laureato al Worcester Polytechnic Institute e ha conseguito un MBA alla Harvard Business School.
Posizioni attive di Brendan Smith
| Società | Posizione | Inizio |
|---|
Precedenti posizioni note di Brendan Smith
| Società | Posizione | Fine |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direttore Finanziario/CFO | 14/03/2023 |
| TRANSLATE BIO, INC. | Direttore Finanziario/CFO | 14/09/2021 |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | 01/03/2021 |
Pfizer AG | Direttore/Membro del Consiglio | - |
Formazione di Brendan Smith
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Translate Bio, Inc.
Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Worcester Polytechnic Institute
Worcester Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer AG | |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
















